Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism. - Test2 - elhamkhani - TriplyDB

Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.

Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.

http://www.wikidata.org/entity/Q34501408

about

The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutations Neuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosis Transcriptional Dynamics at Brain Enhancers: from Functional Specialization to Neurodegeneration Neuroblastoma, a Paradigm for Big Data Science in Pediatric Oncology.The burden of childhood cancer in Mexico: Implications for low- and middle-income countries.Role of non-coding sequence variants in cancer.Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review.Tissue-specific tumorigenesis: context matters.Common variants upstream of MLF1 at 3q25 and within CPZ at 4p16 associated with neuroblastoma.Common genetic variants associated with telomere length confer risk for neuroblastoma and other childhood cancers TAD disruption as oncogenic driver.Exploiting the Epigenome to Control Cancer-Promoting Gene-Expression Programs.LMO1 gene polymorphisms contribute to decreased neuroblastoma susceptibility in a Southern Chinese population.Genome-wide compendium and functional assessment of in vivo heart enhancers.Loss of EGFR-ASAP1 signaling in metastatic and unresectable hepatoblastoma.Deregulation of polycomb repressor complex 1 modifier AUTS2 in T-cell leukemia.Making sense of the cause of Crohn's - a new look at an old disease.Common variations within HACE1 gene and neuroblastoma susceptibility in a Southern Chinese population.Small genomic insertions form enhancers that misregulate oncogenes The Genomic Impact of DNA CpG Methylation on Gene Expression; Relationships in Prostate Cancer Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations.Computational Prediction of Position Effects of Apparently Balanced Human Chromosomal Rearrangements.The functional variant rs34330 of CDKN1B is associated with risk of neuroblastoma.Neuroblastoma in children: Update on clinicopathologic and genetic prognostic factors.The cancer epigenome: Concepts, challenges, and therapeutic opportunities.Enhancer deregulation in cancer and other diseases.Altered TERT promoter and other genomic regulatory elements: occurrence and impact.ChIP-seq in studying epigenetic mechanisms of disease and promoting precision medicine: progresses and future directions.Emergence of the Noncoding Cancer Genome: A Target of Genetic and Epigenetic Alterations.Alternative intronic promoters in development and disease.Genomic Alterations of Non-Coding Regions Underlie Human Cancer: Lessons from T-ALL.Genetic susceptibility to neuroblastoma.Super-Enhancer-Driven Transcriptional Dependencies in Cancer.Associations between LMO1 gene polymorphisms and Wilms' tumor susceptibility.APOBEC signature mutation generates an oncogenic enhancer that drives LMO1 expression in T-ALL GeneHancer: genome-wide integration of enhancers and target genes in GeneCards.Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma.LMO1 polymorphisms reduce neuroblastoma risk in Chinese children: a two-center case-control study.Systematic identification of regulatory variants associated with cancer risk.Transcription instability in high-risk neuroblastoma is associated with a global perturbation of chromatin domains.

P2860

Q26753387-395B0144-A223-417B-B211-14795EFF20D8 Q26774960-D492304C-2124-426E-987F-2A8CC3655970 Q28067751-3849B3BA-041C-4EE9-9745-399CD3661517 Q30239861-1C9FD53D-09FC-430D-B657-507E90867A72 Q30240272-11135E51-708A-4553-9B77-DCF516BAA8C4 Q34509633-E67A3A48-FCD6-4744-A169-84958A05D389 Q34529131-607AF565-64CF-4CF8-96C7-4013F876EE82 Q36296335-B33B7BEB-012C-4E58-850C-BF299E865505 Q36381614-F5B0F7C8-5190-4C11-ADCB-80FCA6278594 Q36926996-D4DE2400-040B-408D-B8E2-67DB7B238FE2 Q36936179-88ACE7A4-B920-488B-8850-00FD8B29536D Q36956610-01B4E34E-9969-42AC-8E58-38020FBD37C7 Q37225669-1B17DC23-CFC2-41BA-A735-F16FCA0D2083 Q37329894-489A9180-B258-4642-8AB5-2D9A381352CF Q37464602-756701BA-2F03-4C36-A279-7624E2FCE311 Q37564432-3D9A82E0-9AC0-4098-815F-1ACC18EA8A70 Q37577712-D81947F0-76B5-4DAE-BAF2-BC88E7A6CC63 Q37641476-EF6A86BF-2A7D-43E5-A1A6-CBEC4C4AC71D Q37642694-311A1696-5F3E-4E80-B76A-ED5487A8D52A Q37729422-A05C1F84-C9AD-44FF-8CB1-A9F03FF8B9AE Q38625880-8FB31178-80A5-4BF0-86AA-1F454D1155C5 Q38666005-957D4609-2909-48AA-B382-9762711559AE Q38698465-F19450E5-D272-4902-AB75-A03E0E66AE25 Q38702196-82914960-8D9D-4F79-9611-C4EDC4C27199 Q38743881-0DF23E5B-9633-425C-AD82-DB8436F19765 Q38826989-1F609089-9AB8-48A7-BFE5-51DD38943229 Q38838144-2F136C9E-747F-464F-8C8F-0159CB57EECB Q38851252-D8270D85-5F93-4377-B48A-83E85CA89CB7 Q38997020-8B24FB60-A3F9-41AB-B818-A967FD23CEEE Q39081179-A27EC7E2-605A-465D-ABD2-A99FA0BC0493 Q39152336-911202EF-CC27-4E2F-904A-903980EEA4BF Q39273903-8CC9FD61-B4DF-4E80-AA19-122741937590 Q39441366-322DF431-F0B9-4E2B-8B6F-628F3467D9AF Q40053313-2F32FDAE-07EE-4AFC-95B9-875CF67FCB65 Q41932009-6B9D07BA-6A6B-43B1-AAFA-9C97CC492FCC Q42208087-9FF55232-0611-474F-B621-B4A1BF26E9CA Q42276835-6DF039F6-4D80-4880-AD7A-553DC688BC7F Q42371564-B60BD2F8-1BE5-4D0E-B076-9D07D915BB45 Q42653906-97C96FBF-E16D-44CE-835B-969F7881135C Q43289708-581ED190-6872-4DBB-B34B-AB6E991ACA6E

P2860

Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.

http://www.wikidata.org/entity/Q34501408

description

2015 nî lūn-bûn

@nan

2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.

@ast

Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.

@en

Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.

@nl

type

label

Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.

@ast

Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.

@en

Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.

@nl

prefLabel

Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.

@ast

Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.

@en

Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.

@nl

P1433

Q34501408-BDD71B48-CD39-4C81-A936-B4AB36E151EF

P1476

Q34501408-0904ABD8-D080-4156-8E73-67FCC0A2BF57

P2093

Q34501408-09FEDB30-85E0-434B-A28F-BCF905AD6B02

Q34501408-0CE98318-DB67-4967-A33F-394A518A08FD

Q34501408-0D4FFC9F-BD8E-46EF-8A12-088651838200

Q34501408-25F7A73C-E5EE-41D8-AA7E-5D5C8800F207

Q34501408-37417EB5-8120-4A05-9094-44AD78CC4FF0

Q34501408-3AAAD9D8-8FF3-4A1A-9AB8-E89E24ECAE55

Q34501408-4ABF62BB-776A-4FB0-BC4F-9A3BD16CF06B

Q34501408-6676A8C8-CB87-4AB8-B53E-52E8BF8CAB3C

Q34501408-6FE0EBBA-648E-4856-B7DE-4151875451C5

Q34501408-81F406E4-36AB-48BC-B757-EF3F87D2B9A5

P2860

Q34501408-06BFDF46-6CCA-4D87-8266-785AFBE63BB1

Q34501408-13B29E4A-08DF-497B-ACF2-C9DAD85FFEE9

Q34501408-169AA981-AED2-4633-BF47-867A060A9A0A

Q34501408-18A118FD-4810-4D81-881E-3F6D8835C6CD

Q34501408-1DC1B873-5F6E-4532-8406-6DB2BD92E2B0

Q34501408-2BD902AD-20BE-49BC-9CEA-159B6C3C2A40

Q34501408-2EE611BC-37CB-4612-8C0E-003B06E74DDD

Q34501408-42FDFFC6-8342-46C2-8F0B-690C4A3FB06A

Q34501408-47A6630F-3129-48D1-AEDF-49DBB053F7F2

Q34501408-498FCB0F-A549-4AB6-BB44-757C21537721

P2888

Q34501408-16DAD966-E220-4E7B-8F33-F088909B9067

P304

Q34501408-9EB6FE8F-8600-4A83-BA81-36FBCCFA7827

P31

Q34501408-92f7ff0e-70ca-47e5-b8b9-f63926715a4f

Q34501408-95B8868C-F68C-48DC-A52E-66A29EF66800

P356

Q34501408-1050AF8F-86E6-468B-B74F-F1753E54BF2B

P407

Q34501408-7A745C56-8836-4BB8-8CC5-4431B777498D

P433

Q34501408-8D23CC5B-BF47-4221-8694-3E04D4F2BFD6

P478

Q34501408-FC4EDC2B-C08B-43DF-85FA-2A56AAEBD739

P50

Q34501408-AA9D6E6B-5CD1-410F-8AC8-28636F38241D

Q34501408-B8D2515F-1B33-4B01-A642-68928E287340

Q34501408-C46A1B40-553A-4815-8DB4-0AF8FECE1306

Q34501408-C5CCF240-9E5B-43CA-A0CB-D18C2894E3DF

Q34501408-E2C1388F-AB66-4394-BE04-A72E42CBC051

Q34501408-E5EB5395-8332-43B9-9F5C-680D77547BCE

P577

Q34501408-A7C376EC-2159-454F-BAB6-D4F3491C4265

P5875

Q34501408-1E6DEF44-3587-4F0B-A58B-421C8CBBDCD8

P698

Q34501408-E6250296-E2C2-4495-B9A1-3B047814F50C

P921

Q34501408-237d19d2-49f8-2d1c-fed9-823b17373f99

P932

Q34501408-4A3E86E0-B886-4CF5-A6B5-5160F9A959CF

P356

P1433

P1476

Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism

@en

P2093

A Thomas Look

http://www.w3.org/2001/XMLSchema#string

Achille Iolascon

http://www.w3.org/2001/XMLSchema#string

Andrew C Wood

http://www.w3.org/2001/XMLSchema#string

Cynthia Winter

http://www.w3.org/2001/XMLSchema#string

Daniela S Gerhard

http://www.w3.org/2001/XMLSchema#string

Derek A Oldridge

http://www.w3.org/2001/XMLSchema#string

Hakon Hakonarson

http://www.w3.org/2001/XMLSchema#string

Ian Crimmins

http://www.w3.org/2001/XMLSchema#string

Jaime M Guidry Auvil

http://www.w3.org/2001/XMLSchema#string

Javed Khan

http://www.w3.org/2001/XMLSchema#string

P2860

Ultrafast and memory-efficient alignment of short DNA sequences to the human genome

Model-based analysis of ChIP-Seq (MACS)

Histone H3K27ac separates active from poised enhancers and predicts developmental state

Copy number variation at 1q21.1 associated with neuroblastoma

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

Chromosome 6p22 locus associated with clinically aggressive neuroblastoma

The human genome browser at UCSC

The Sequence Alignment/Map format and SAMtools

Immunoaffinity purification of mammalian protein complexes

Controlling long-range genomic interactions at a native locus by targeted tethering of a looping factor

P2888

P304

418-421

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NATURE15540

http://www.w3.org/2001/XMLSchema#string

P407

P433

7582

http://www.w3.org/2001/XMLSchema#string

P478

528

http://www.w3.org/2001/XMLSchema#string

P50

Brian J. Abraham

Robyn T Sussman

P577

2015-11-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283686585

http://www.w3.org/2001/XMLSchema#string

P698

26560027

http://www.w3.org/2001/XMLSchema#string

P921

P932

4775078

http://www.w3.org/2001/XMLSchema#string